Medy-Tox Inc. is a South Korean biopharmaceutical company specializing in the research, development, and commercialization of botulinum toxin products used in aesthetic and therapeutic applications.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!